Ryan Cole

Ryan Cole is a declared insider of Aurinia Pharmaceuticals Inc., with filings sourced from SEC (Form 4). Between 23 March 2026 and 18 May 2026, the trades on record add up to 4 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The latest filing, published on 27 May 2026, reports a share grant in Aurinia Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 37 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.